Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
Adenosine rest-stress perfusion may represent nearly half the imaging volume at some clinics, but due to safety questions some physicians are sticking with dobutamine for pharmacological stress testing.
A study of adenosine safety conducted by researchers at St. Marien Hospital in Bonn, Germany, may put those concerns to rest. Dr. Karol Miszlaski-Jamka did record minor side effects, such as facial flushing and mild shortness of breath, in 81% of the 645 patients who underwent adenosine-stress contrast MR. But major side effects were limited, including 23 cases of transient high-degree atrioventricular block that resolved spontaneously, one case of severely increased blood pressure, and two instances of claustrophobia.
Study affirms safety . . .
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.